Five things for pharma marketers to know: Wednesday, January 20, 2021
Black Americans getting vaccinated at much lower rates; companies rush to develop new drugs to beat COVID-19 variants; remote care startup K Health raises $132 million.
News
PoC3 releases revised point-of-care guidance
New guidance updates best practices around auditing, transparency.
Five things for pharma marketers to know: Tuesday, January 19, 2021
Biden proposes $1.9 trillion COVID-19 aid package; Eli Lilly boosts diversity pledge; tech companies work to create vaccination record system.
5 health-tech trends from this year’s CES
Telemedicine, digital therapeutics and “health at home” took center (virtual) stage at the increasingly health-centric event.
The Escalator: AskBio appoints president of therapeutics
Plus personnel moves at Amylyx Pharmaceuticals, Finn Partners and Healthline Media.
Until we meet again: Reflections from a JPMorgan Health Conference like no other
There were pluses and minuses to attending from afar.
Five things for pharma marketers to know: Friday, January 15, 2021
Woodcock under consideration to lead FDA; Biden advisor expects slowdown in new vaccine plan; Accolade to buy telemedicine startup.
JPMorgan Day 4: U.S. and Israeli leaders assess COVID’s past, present and future
Plus former Secretary of State Condoleezza Rice weighs in on her hopes for the Biden administration.
Fishawack adds StoneArch to expanding agency roster
The deal comes on the heels of last week’s purchase of Hive Health.
Pharmacies take center stage at day three of JPM
Every crisis has its winners and losers, and this once-in-a-generation pandemic is no exception.
Want to read more?
Please login or register first to view this content.
